Relationship Between Loss of Y Chromosome and Urologic Cancers: New Future Perspectives
Pierluigi Russo(Università Cattolica del Sacro Cuore), Nazario Foschi(Agostino Gemelli University Polyclinic), Filippo Marino(Università Cattolica del Sacro Cuore), Chiara Ciccarese(Agostino Gemelli University Polyclinic), Mauro Ragonese(Agostino Gemelli University Polyclinic), Valentina Trevisan(Agostino Gemelli University Polyclinic), Stijn Muselaers(Radboud University Nijmegen), Luigi Boccuto(Greenwood Genetic Center), Marco Racioppi(Università Cattolica del Sacro Cuore), Giovanni Battista Filomena(Università Cattolica del Sacro Cuore), Emilio Sacco(Università Cattolica del Sacro Cuore), Roberto Iacovelli(Agostino Gemelli University Polyclinic), Filippo Gavi(Università Cattolica del Sacro Cuore), Giuseppe Palermo(Agostino Gemelli University Polyclinic), Savio Domenico Pandolfo(University of L'Aquila), C Savoia(Università Cattolica del Sacro Cuore), Roberto Falabella(Azienda Ospedaliera Ospedale San Carlo Borromeo), Chiara Leoni(Agostino Gemelli University Polyclinic), Francesco Rossi(Università Cattolica del Sacro Cuore), Francesco Pio Bizzarri(Università Cattolica del Sacro Cuore), Paolo Pietro Suraci, Luigi Napolitano(University of Naples Federico II)
Cited by 43
Related Papers
Prevalence of SHANK3 variants in patients with different subtypes of autism spectrum disorders
|European Journal of Human Genetics|2012|248
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
|International Journal of Molecular Sciences|2022|190
Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice
|Biomedicines|2023|161
Association of NAFLD and Insulin Resistance with Non Metastatic Bladder Cancer Patients: A Cross-Sectional Retrospective Study
|Journal of Clinical Medicine|2021|131
Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma
|Journal of Clinical Medicine|2023|129